Y
Yazid Belkacemi
Researcher at University of Paris-Est
Publications - 227
Citations - 6173
Yazid Belkacemi is an academic researcher from University of Paris-Est. The author has contributed to research in topics: Radiation therapy & Breast cancer. The author has an hindex of 34, co-authored 208 publications receiving 5002 citations. Previous affiliations of Yazid Belkacemi include French Institute of Health and Medical Research & Paris 12 Val de Marne University.
Papers
More filters
Journal ArticleDOI
Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial
M. Donker,Geertjan van Tienhoven,Marieke E. Straver,P. Meijnen,Cornelis J.H. van de Velde,Robert E. Mansel,Luigi Cataliotti,A. Helen Westenberg,Jean H. G. Klinkenbijl,Lorenzo Orzalesi,Willem H. Bouma,Huub van der Mijle,Grard A. P. Nieuwenhuijzen,Sanne C. Veltkamp,Leen Slaets,Nicole Duez,Peter W. de Graaf,Thijs van Dalen,A. Marinelli,Herman Rijna,Marko Snoj,Nigel J Bundred,Jos W. S. Merkus,Yazid Belkacemi,Patrick Petignat,Dominic A.X. Schinagl,Corneel Coens,Carlo Messina,Jan Bogaerts,Emiel J. Th. Rutgers +29 more
TL;DR: The AMAROS trial as discussed by the authors evaluated axillary lymph node dissection and axillary radiotherapy for T1-2 primary breast cancer and no palpable lymphadenopathy patients with positive sentinel nodes.
Journal ArticleDOI
Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer.
Emmanuel Touboul,Laurent Buffat,Yazid Belkacemi,Jean-Pierre Lefranc,Serge Uzan,Pierre Lhuillier,Corinne Faivre,Judith Huart,Jean-Pierre Lotz,Martine Antoine,F. Pene,Jean Blondon,V. Izrael,Alain Laugier,Michel Schlienger,Martin Housset +15 more
TL;DR: To identify predicting factors for local failure and increased risk of distant metastases by statistical analysis of the data after breast-conserving treatment for early breast cancer, a large sample of patients with nonmetastatic carcinoma of the breast was analyzed.
Journal ArticleDOI
Phyllodes Tumor of the Breast
Yazid Belkacemi,Guilhem Bousquet,Hugo Marsiglia,Hugo Marsiglia,I. Ray-Coquard,Nicolas Magné,Yann Malard,Magalie Lacroix,Cristina Gutierrez,Elżbieta Senkus,David R. H. Christie,Karen Drumea,Edouard Lagneau,Sidney P. Kadish,Luciano Scandolaro,David Azria,Mahmut Ozsahin +16 more
TL;DR: This study showed that phyllodes tumor patients with no RD after treatment have better local control andBenign tumors have a good prognosis after surgery alone, and adjuvant RT should be considered according to histologic criteria.
Journal ArticleDOI
Outcomes and patterns of failure in solitary plasmacytoma: A multicenter Rare Cancer Network study of 258 patients
Mahmut Ozsahin,Richard W. Tsang,Philip Poortmans,Yazid Belkacemi,Michel Bolla,Fazilet Oner Dincbas,Christine Landmann,Bernard Castelain,Jeroen Buijsen,Jürgen Curschmann,Sidney P. Kadish,Anna Kowalczyk,Yavuz Anacak,Josef Hammer,Tan D. Nguyen,Gabriela Studer,Rachel A Cooper,Meric Sengoz,Luciano Scandolaro,Abderrahim Zouhair +19 more
TL;DR: Progression to MM remains the main problem, but patients with extramedullary SP had the best outcomes, especially when treated with moderate-dose RT, and Chemotherapy and/or novel therapies should be investigated for bone or bulky extrameastern SP.
Journal ArticleDOI
Adjuvant radiotherapy versus early salvage radiotherapy plus short-term androgen deprivation therapy in men with localised prostate cancer after radical prostatectomy (GETUG-AFU 17): a randomised, phase 3 trial.
Paul Sargos,Sylvie Chabaud,Igor Latorzeff,Nicolas Magné,A. Benyoucef,Stéphane Supiot,David Pasquier,Menouar Samir Abdiche,Olivier Gilliot,Pierre Graff-Cailleaud,Marlon Silva,Philippe Bergerot,Pierre Baumann,Yazid Belkacemi,David Azria,Meryem Brihoum,Michel Soulié,Pierre Richaud +17 more
TL;DR: A policy of early salvage radiotherapy could spare men from overtreatment with radiotherapy and the associated adverse events, and a policy of adjuvant radiotherapy increased the risk of genitourinary toxicity and erectile dysfunction.